← Back to All Filings

UnitedHealth Group Director Paul R. Garcia Receives Routine Quarterly Equity Grant

Low SignificanceOctober 5, 2026 at 5:08:52 PM EDT

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 Form 4 Filing: UnitedHealth Group Inc ($UNH) Insider: Garcia Paul R (Director) Transaction: Grant/Award (Code A) Shares Acquired: 258 shares @ $0.00 (Total Value: $0.00) Direct Shares Owned After: 4,180 shares Significance: Low (Routine quarterly director compensation)

Comprehensive Analysis

Executive Summary

On October 5, 2026, UnitedHealth Group Inc ($UNH) director Paul R. Garcia reported the acquisition of 258 shares of common stock on October 1, 2026. The transaction consists of standard quarterly director compensation grants awarded at $0 per share, resulting in a low trading significance rating.

Transaction Breakdown

  • Deferred Stock Units: 155 shares granted as deferred stock units, immediately vested but held until termination of Board service.
  • Direct Common Stock: 103 shares granted as direct common stock.
  • Total Consideration: $0.00 (Routine non-employee director compensation).
  • Beneficial Ownership Following Transactions:
    • Directly owned: 4,180 shares
    • Indirectly owned: 2,246 shares (2,146 via Revocable Trust, 45 via Trust 2, and 55 via Trust 3)

Market & Governance Impact

This filing reflects regular, predetermined quarterly equity compensation for board service and does not indicate an open-market purchase or sale. Because the transaction represents routine compensation rather than discretionary buying, it carries no predictive market signaling value.

Topics:#UNH#UnitedHealth#InsiderTrading#SECForm4#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.